Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.H.S., Duke University 2011
  • Fellow in Pulmonary Medicine, Medicine, Duke University 2003 - 2006
  • Medical Resident, Medicine, University of California San Francisco, School of Medicine 2000 - 2003
  • M.D., Duke University 2000
• 

  Previous Appointments & Affiliations

  • Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2020 - 2022
  • Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2020
  • Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2015 - 2020
  • Assistant Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2009 - 2015
  • Medical Instructor in the Department of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2006 - 2009
  • Instructor, Temporary in the Department of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine 2006
• 

  Leadership & Clinical Positions at Duke

  • Medical Director, Medicine Clinical Research Unit, Department of Medicine
    Associate Medical Director, Duke Lung Transplant Program
• Research
• 

  Selected Grants

  • Lung Transplant Clinical Trial Network (LT-CTN) awarded by National Institutes of Health 2021 - 2028
  • Clinical and Mechanistic Factors Impacting Transplant Outcomes (U01) awarded by National Institutes of Health 2022 - 2027
  • Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER) awarded by National Institutes of Health 2022 - 2026
  • Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary Disease awarded by National Institutes of Health 2022 - 2026
  • A Phase III, Multicentre, Randomised, Double-blind, Chronic Dosing, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 in Participants with Symptomatic Chronic Obstructive Pulmonary Disease awarded by MedImmune Limited 2021 - 2024
  • Improving Lung Transplant Outcomes with Coping Skills and Physical Activity awarded by National Institutes of Health 2019 - 2024
  • Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG) awarded by National Institutes of Health 2018 - 2023
  • Long Term Follow up of the Lung Transplant Outcomes Group Cohort awarded by University of Pennsylvania 2022 - 2023
  • CF LTT RDN Expansion Mini Grant Funding awarded by University of New Hampshire 2021 - 2022
  • Cystic Fibrosis Lung Transplant Consortium awarded by Cystic Fibrosis Foundation 2020 - 2022
  • Duke - UNC Cystic Fibrosis Tissue Procurement Partnership awarded by Cystic Fibrosis Foundation 2018 - 2022
  • Clinical and Molecular Epidemiology of Acute Kidney Injury After Lung Transplant awarded by University of Pennsylvania 2017 - 2022
  • Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab awarded by Massachusetts General Hospital 2021 - 2022
  • AZ Pulse Ox Study_LOI awarded by AstraZeneca LP 2021 - 2022
  • Cystic Fibrosis Lung Transplant and Transition Regional Dissemination Network - Mini-Grant for Continued Quality Improvement awarded by University of New Hampshire 2021
  • DeNovo DSA to predict treatment response awarded by Icahn School of Medicine at Mount Sinai 2020 - 2021
  • CTOT Long-Term Extension Study awarded by Cystic Fibrosis Foundation 2019 - 2021
  • The Lung Transplant Clinical Trials Network (LT-CTN) awarded by National Institutes of Health 2014 - 2021
  • Impact of patient specific factors on CF lung transplant outcomes awarded by University of Pennsylvania 2019 - 2020
  • Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization awarded by Bristol-Myers Squibb Company 2019 - 2020
  • Cystic Fibrosis Lung Transplant Transition - Regional Dissemination Network awarded by Dartmouth College 2019 - 2020
  • Cystic Fibrosis Lung Transplant Consortium awarded by Cystic Fibrosis Foundation Therapeutics, Inc. 2017 - 2019
  • The interface of B and T cells in Transplant awarded by Cystic Fibrosis Foundation Therapeutics, Inc. 2016 - 2019
  • CF Lung Transplant Transition LLC Phase 2 Program Extension Post NACFC October 2018 through May 30, 2019 awarded by Dartmouth College 2018 - 2019
  • Clinical features of lung transplant recipients with prolonged survival (>15 years) from the ISHLT registry awarded by International Society for Heart & Lung Transplantation 2018 - 2019
  • Clinical Risk Factors for Primary Graft Dysfunction awarded by University of Pennsylvania 2015 - 2018
  • Predictors and Outcomes of Post-transplant lymphoproliferative disorder in lung transplant recipients awarded by International Society for Heart & Lung Transplantation 2017 - 2018
  • GS-US-218-1797 awarded by Gilead Sciences, Inc. 2015 - 2017
  • Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation awarded by Mount Sinai School of Medicine 2016 - 2017
  • eConnectivity COPD Study LOI awarded by Teva Pharmaceutical Industries, Ltd 2017
  • Novel Cellular Immune Profiles to Predict Lung Disease Outcomes awarded by National Institutes of Health 2011 - 2013
• 

  External Relationships

  • Aztra Zeneca
  • NuvoAir
  • Pulmocide
  • Qx therapeutics
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Shino, Michael Y., Jamie L. Todd, Megan L. Neely, Jerry Kirchner, Courtney W. Frankel, Laurie D. Snyder, Elizabeth N. Pavlisko, et al. “Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.” Am J Transplant 22, no. 9 (September 2022): 2169–79. https://doi.org/10.1111/ajt.17108.
       Full Text  Link to Item
    • Pavlisko, Elizabeth N., Megan L. Neely, Heather Kopetskie, David M. Hwang, Carol F. Farver, W Dean Wallace, Andrea Arrossi, et al. “Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.” Am J Transplant, August 29, 2022. https://doi.org/10.1111/ajt.17183.
       Full Text  Link to Item
    • Dalton, Tara, Laurie D. Snyder, Erika Bush Buckley, and Patrick J. Smith. “Pretransplant physical frailty, postoperative delirium, and short-term outcomes among older lung transplant recipients.” Exp Gerontol 163 (June 15, 2022): 111781. https://doi.org/10.1016/j.exger.2022.111781.
       Full Text  Link to Item
    • Krischak, Madison K., Sandra Au, Samantha E. Halpern, Danae G. Olaso, Dimitrios Moris, Laurie D. Snyder, Andrew S. Barbas, John C. Haney, Jacob A. Klapper, and Matthew G. Hartwig. “Textbook surgical outcome in lung transplantation: Analysis of a US national registry.” Clin Transplant 36, no. 4 (April 2022): e14588. https://doi.org/10.1111/ctr.14588.
       Full Text  Link to Item
    • Saullo, Jennifer L., Arthur W. Baker, Laurie D. Snyder, John M. Reynolds, Lorenzo Zaffiri, Emily M. Eichenberger, Alana Ferrari, et al. “Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis.” J Heart Lung Transplant 41, no. 4 (April 2022): 508–15. https://doi.org/10.1016/j.healun.2021.12.005.
       Full Text  Link to Item
    • Kim, Hyun J., Laurie D. Snyder, Megan L. Neely, Anne S. Hellkamp, David L. Hotchkin, Lake D. Morrison, Shaun Bender, Thomas B. Leonard, Daniel A. Culver, and Daniel A. IPF-PRO^TM Registry investigators. “Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.” Lung 200, no. 1 (February 2022): 21–29. https://doi.org/10.1007/s00408-021-00506-x.
       Full Text  Link to Item
    • Andrade, Joao A. de, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Daniel A. Culver, Kalpalatha Guntupalli, et al. “Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.” Respir Res 23, no. 1 (January 7, 2022): 3. https://doi.org/10.1186/s12931-021-01921-7.
       Full Text  Link to Item
    • Crespo, Maria M., Erika D. Lease, Amparo Sole, Nora Sandorfi, Laurie D. Snyder, Gerald J. Berry, Jérôme Le Pavec, et al. “ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements.” J Heart Lung Transplant 40, no. 11 (November 2021): 1251–66. https://doi.org/10.1016/j.healun.2021.07.014.
       Full Text  Link to Item
    • Shino, Michael Y., Ning Li, Jamie L. Todd, Megan L. Neely, Jerry Kirchner, Heather Kopetskie, Michelle L. Sever, et al. “Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.” Am J Transplant 21, no. 10 (October 2021): 3401–10. https://doi.org/10.1111/ajt.16601.
       Full Text  Link to Item
    • Kim, Hyun J., Laurie D. Snyder, Ayodeji Adegunsoye, Megan L. Neely, Shaun Bender, Eric S. White, Craig S. Conoscenti, Mary E. Strek, and Mary E. IPF-PRO Registry Investigators. “Hospitalizations in patients with idiopathic pulmonary fibrosis.” Respir Res 22, no. 1 (September 30, 2021): 257. https://doi.org/10.1186/s12931-021-01851-4.
       Full Text  Link to Item
    • Smith, PatrickJ, Apoorva Kandakatla, Courtney W. Frankel, Daniel R. Bacon, Erika Bush, Robert J. Mentz, and Laurie D. Snyder. “Sleep quality, depressive symptoms, and transplant outcomes: Follow-up analyses from the ADAPT prospective pilot study.” Gen Hosp Psychiatry 72 (September 2021): 53–58. https://doi.org/10.1016/j.genhosppsych.2021.06.011.
       Full Text  Link to Item
    • Schaenman, Joanna M., Joshua M. Diamond, John R. Greenland, Cynthia Gries, Cassie C. Kennedy, Amit D. Parulekar, Dmitry Rozenberg, et al. “Frailty and aging-associated syndromes in lung transplant candidates and recipients.” Am J Transplant 21, no. 6 (June 2021): 2018–24. https://doi.org/10.1111/ajt.16439.
       Full Text  Link to Item
    • Martinez, Fernando J., Eric Yow, Kevin R. Flaherty, Laurie D. Snyder, Michael T. Durheim, Stephen R. Wisniewski, Frank C. Sciurba, et al. “Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.” Jama 325, no. 18 (May 11, 2021): 1841–51. https://doi.org/10.1001/jama.2021.4956.
       Full Text  Link to Item
    • Natalini, Jake G., Joshua M. Diamond, Mary K. Porteous, David J. Lederer, Keith M. Wille, Ann B. Weinacker, Jonathan B. Orens, et al. “Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.” J Heart Lung Transplant 40, no. 5 (May 2021): 351–58. https://doi.org/10.1016/j.healun.2021.01.1391.
       Full Text  Link to Item
    • Hostetler, Haley P., Megan L. Neely, Francine L. Kelly, John A. Belperio, Marie Budev, John M. Reynolds, Pali D. Shah, et al. “Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection.” Transplant Direct 7, no. 4 (April 2021): e685. https://doi.org/10.1097/TXD.0000000000001138.
       Full Text  Link to Item
    • Kraft, Bryan D., Kamran Mahmood, Nicole P. Harlan, Matthew G. Hartwig, Laurie D. Snyder, Hagir B. Suliman, and Scott L. Shofer. “Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.” J Heart Lung Transplant 40, no. 4 (April 2021): 269–78. https://doi.org/10.1016/j.healun.2021.01.008.
       Full Text  Link to Item
    • Neely, Megan L., Scott M. Palmer, and Laurie D. Snyder. “Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing.” Am J Transplant 21, no. 2 (February 2021): 456–57. https://doi.org/10.1111/ajt.16313.
       Full Text  Link to Item
    • Young, Katherine A., Hakim A. Ali, Kristi J. Beermann, John M. Reynolds, and Laurie D. Snyder. “Lung Transplantation and the Era of the Sensitized Patient.” Front Immunol 12 (2021): 689420. https://doi.org/10.3389/fimmu.2021.689420.
       Full Text  Link to Item
    • Chu, Michael C., Patrick J. Smith, John M. Reynolds, Scott M. Palmer, Laurie D. Snyder, Alice L. Gray, and James A. Blumenthal. “Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients.” Int J Psychiatry Med 55, no. 6 (November 2020): 421–36. https://doi.org/10.1177/0091217420906637.
       Full Text  Link to Item
    • Anderson, Michaela R., Imaani Easthausen, Grace Gallagher, Jayaram Udupa, Yubing Tong, Drew Torigian, Joshua Matthew Diamond, et al. “Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study.” Thorax 75, no. 9 (September 2020): 801–4. https://doi.org/10.1136/thoraxjnl-2019-214461.
       Full Text  Link to Item
    • Zhang, Chen Yang Kevin, Musawir Ahmed, Ella Huszti, Liran Levy, Sarah E. Hunter, Kristen M. Boonstra, Sajad Moshkelgosha, et al. “Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.” J Heart Lung Transplant 39, no. 9 (September 2020): 934–44. https://doi.org/10.1016/j.healun.2020.05.006.
       Full Text  Link to Item
    • Todd, Jamie L., Megan L. Neely, Heather Kopetskie, Michelle L. Sever, Jerry Kirchner, Courtney W. Frankel, Laurie D. Snyder, et al. “Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study.” Am J Respir Crit Care Med 202, no. 4 (August 15, 2020): 576–85. https://doi.org/10.1164/rccm.201910-1915OC.
       Full Text  Link to Item
    • Snyder, Laurie D., Christopher Mosher, Colin H. Holtze, Lisa H. Lancaster, Kevin R. Flaherty, Imre Noth, Megan L. Neely, et al. “Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.” Bmj Open Respir Res 7, no. 1 (July 2020). https://doi.org/10.1136/bmjresp-2020-000567.
       Full Text  Link to Item
    • Tsuang, Wayne M., Laurie D. Snyder, and Marie M. Budev. “Perspectives on donor lung allocation from both sides of the Atlantic: The United States.” Clin Transplant 34, no. 7 (July 2020): e13873. https://doi.org/10.1111/ctr.13873.
       Full Text  Link to Item
    • Case, Amy Hajari, Anne S. Hellkamp, Megan L. Neely, Shaun Bender, Daniel F. Dilling, Mridu Gulati, David L. Hotchkin, et al. “Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.” Ann Am Thorac Soc 17, no. 6 (June 2020): 699–705. https://doi.org/10.1513/AnnalsATS.201906-437OC.
       Full Text  Link to Item
    • Snyder, Laurie D., John Belperio, Marie Budev, Courtney Frankel, Jerry Kirchner, Tereza Martinu, Megan L. Neely, et al. “Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant.” Am J Transplant 20, no. 6 (June 2020): 1489–94. https://doi.org/10.1111/ajt.15957.
       Full Text  Link to Item
    • O’Brien, Emily C., Anne S. Hellkamp, Megan L. Neely, Aparna Swaminathan, Shaun Bender, Laurie D. Snyder, Daniel A. Culver, et al. “Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.” Chest 157, no. 5 (May 2020): 1188–98. https://doi.org/10.1016/j.chest.2019.11.042.
       Full Text  Link to Item
    • Weigt, S Samuel, and Laurie D. Snyder. “Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway.” Am J Transplant 20, no. 4 (April 2020): 920–21. https://doi.org/10.1111/ajt.15741.
       Full Text  Link to Item
    • Anstrom, Kevin J., Imre Noth, Kevin R. Flaherty, Rex H. Edwards, Joan Albright, Amanda Baucom, Maria Brooks, et al. “Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.” Respir Res 21, no. 1 (March 12, 2020): 68. https://doi.org/10.1186/s12931-020-1326-1.
       Full Text  Link to Item
    • Blumenthal, James A., Patrick J. Smith, Andrew Sherwood, Stephanie Mabe, Laurie Snyder, Courtney Frankel, Daphne C. McKee, et al. “Remote Therapy to Improve Outcomes in Lung Transplant Recipients: Design of the INSPIRE-III Randomized Clinical Trial.” Transplant Direct 6, no. 3 (March 2020): e535. https://doi.org/10.1097/TXD.0000000000000979.
       Full Text  Link to Item
    • Smith, Patrick J., Courtney W. Frankel, Daniel R. Bacon, Erika Bush, Robert J. Mentz, and Laurie D. Snyder. “Depressive symptoms, physical activity, and clinical events: The ADAPT prospective pilot study.” Clin Transplant 33, no. 11 (November 2019): e13710. https://doi.org/10.1111/ctr.13710.
       Full Text  Link to Item
    • Swaminathan, Aparna C., Megan L. Neely, Courtney W. Frankel, Fran L. Kelly, Slavé Petrovski, Michael T. Durheim, Erika Bush, et al. “Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants.” Chest 156, no. 3 (September 2019): 477–85. https://doi.org/10.1016/j.chest.2019.03.030.
       Full Text  Link to Item
    • Cheng, Tracy Z., Kevin J. Choi, Adam L. Honeybrook, Rasheedat T. Zakare-Fagbamila, Alice L. Gray, Laurie D. Snyder, Scott M. Palmer, Ralph Abi-Hachem, and David W. Jang. “Decreased Antibiotic Utilization After Sinus Surgery in Cystic Fibrosis Patients With Lung Transplantation.” Am J Rhinol Allergy 33, no. 4 (July 2019): 354–58. https://doi.org/10.1177/1945892419830624.
       Full Text  Link to Item
    • Snyder, Laurie D., and Lianne G. Singer. “Beyond the eyeball test: Measures of frailty in lung transplantation.” J Heart Lung Transplant 38, no. 7 (July 2019): 708–9. https://doi.org/10.1016/j.healun.2019.05.003.
       Full Text  Link to Item
    • Snyder, Laurie, Megan L. Neely, Anne S. Hellkamp, Emily O’Brien, Joao de Andrade, Craig S. Conoscenti, Thomas Leonard, et al. “Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.” Respir Res 20, no. 1 (May 30, 2019): 105. https://doi.org/10.1186/s12931-019-1043-9.
       Full Text  Link to Item
    • Bottiger, Brandi A., Alina Nicoara, Laurie D. Snyder, Paul E. Wischmeyer, Jacob N. Schroder, Chetan B. Patel, Mani A. Daneshmand, Robert N. Sladen, and Kamrouz Ghadimi. “Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.” J Cardiothorac Vasc Anesth 33, no. 5 (May 2019): 1382–92. https://doi.org/10.1053/j.jvca.2018.08.002.
       Full Text  Link to Item
    • Byrd, Rebecca, Patrick Smith, Omar Mohamedaly, Laurie D. Snyder, and Amy M. Pastva. “A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life.” Cardiopulm Phys Ther J 30, no. 2 (April 2019): 61–69. https://doi.org/10.1097/CPT.0000000000000087.
       Full Text  Link to Item
    • Clausen, Emily Siu, Courtney Frankel, Scott M. Palmer, Laurie D. Snyder, and Patrick J. Smith. “Pre-transplant weight loss and clinical outcomes after lung transplantation.” J Heart Lung Transplant 37, no. 12 (December 2018): 1443–47. https://doi.org/10.1016/j.healun.2018.07.015.
       Full Text  Link to Item
    • Mulligan, Michael S., David Weill, R Duane Davis, Jason D. Christie, Farhood Farjah, Jonathan P. Singer, Matthew Hartwig, et al. “National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.” J Thorac Cardiovasc Surg 156, no. 6 (December 2018): 2355–65. https://doi.org/10.1016/j.jtcvs.2018.08.010.
       Full Text  Link to Item
    • Palmer, Scott M., Laurie Snyder, Jamie L. Todd, Benjamin Soule, Rose Christian, Kevin Anstrom, Yi Luo, Robert Gagnon, and Glenn Rosen. “Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.” Chest 154, no. 5 (November 2018): 1061–69. https://doi.org/10.1016/j.chest.2018.08.1058.
       Full Text  Link to Item
    • Snyder, Laurie D., and Kathryn J. Tinckam. “Another piece of the antibody puzzle: Observations from the HALT study.” Am J Transplant 18, no. 9 (September 2018): 2111–12. https://doi.org/10.1111/ajt.14959.
       Full Text  Link to Item
    • Tambur, Anat R., Patricia Campbell, Frans H. Claas, Sandy Feng, Howard M. Gebel, Annette M. Jackson, Roslyn B. Mannon, et al. “Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.” Am J Transplant 18, no. 7 (July 2018): 1604–14. https://doi.org/10.1111/ajt.14752.
       Full Text  Link to Item
    • Smith, Patrick J., Laurie D. Snyder, Scott M. Palmer, Benson M. Hoffman, Gregory L. Stonerock, Krista K. Ingle, Caroline K. Saulino, and James A. Blumenthal. “Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study.” Transpl Int 31, no. 5 (May 2018): 495–502. https://doi.org/10.1111/tri.13094.
       Full Text  Link to Item
    • Smith, Patrick J., Rebecca Byrd, Megan Lusby, Emily Clausen, and Laurie D. Snyder. “Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation.” Psychosom Med 80, no. 4 (May 2018): 403–9. https://doi.org/10.1097/PSY.0000000000000573.
       Full Text  Link to Item
    • Ali, Hakim Azfar, Elizabeth N. Pavlisko, Laurie D. Snyder, Michael Frank, and Scott M. Palmer. “Complement system in lung transplantation.” Clin Transplant 32, no. 4 (April 2018): e13208. https://doi.org/10.1111/ctr.13208.
       Full Text  Link to Item
    • Smith, Patrick J., Gregory L. Stonerock, Krista K. Ingle, Caroline K. Saulino, Benson Hoffman, Brian Wasserman, James A. Blumenthal, et al. “Neurological Sequelae and Clinical Outcomes After Lung Transplantation.” Transplant Direct 4, no. 4 (April 2018): e353. https://doi.org/10.1097/TXD.0000000000000766.
       Full Text  Open Access Copy  Link to Item
    • Choi, Kevin J., Tracy Z. Cheng, Adam L. Honeybrook, Alice L. Gray, Laurie D. Snyder, Scott M. Palmer, Ralph Abi Hachem, and David W. Jang. “Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis.” Int Forum Allergy Rhinol 8, no. 3 (March 2018): 389–93. https://doi.org/10.1002/alr.22067.
       Full Text  Link to Item
    • Cantu, Edward, Joshua M. Diamond, Yoshikazu Suzuki, Jared Lasky, Christian Schaufler, Brian Lim, Rupal Shah, et al. “Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.” Am J Respir Crit Care Med 197, no. 2 (January 15, 2018): 235–43. https://doi.org/10.1164/rccm.201706-1140OC.
       Full Text  Link to Item
    • Farquhar, Julia M., Patrick J. Smith, Laurie Snyder, Alice L. Gray, John M. Reynolds, and James A. Blumenthal. “Patterns and predictors of pain following lung transplantation.” Gen Hosp Psychiatry 50 (January 2018): 125–30. https://doi.org/10.1016/j.genhosppsych.2017.11.007.
       Full Text  Link to Item
    • Szczepanik, Amanda, Amanda Hulbert, Hui-Jie Lee, Clark Benedetti, Laurie Snyder, and Jennifer Byrns. “Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.” Clin Transplant 32, no. 1 (January 2018). https://doi.org/10.1111/ctr.13156.
       Full Text  Link to Item
    • Gulack, Brian C., Michael S. Mulvihill, Asvin M. Ganapathi, Paul J. Speicher, Godefroy Chery, Laurie D. Snyder, R Duane Davis, and Matthew G. Hartwig. “Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study.” Transpl Int 31, no. 1 (January 2018): 45–55. https://doi.org/10.1111/tri.13038.
       Full Text  Link to Item
    • Clausen, Emily S., and Laurie D. Snyder. “Do donors matter? Short telomeres and survival after lung transplant.” Thorax 72, no. 11 (November 2017): 965–66. https://doi.org/10.1136/thoraxjnl-2017-210363.
       Full Text  Link to Item
    • Abbes, Sarah, Ara Metjian, Alice Gray, Tereza Martinu, Laurie Snyder, Dong-Feng Chen, Matthew Ellis, Gowthami M. Arepally, and Oluwatoyosi Onwuemene. “Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner.” Ther Apher Dial 21, no. 5 (October 2017): 441–50. https://doi.org/10.1111/1744-9987.12570.
       Full Text  Link to Item
    • Zaffiri, L., A. Hulbert, and L. D. Snyder. “Pre-transplant Sensitization for Patient Awaiting Lung Transplant: Are We Concerned?” Current Transplantation Reports 4, no. 3 (September 1, 2017): 211–17. https://doi.org/10.1007/s40472-017-0155-8.
       Full Text
    • McClellan, Taylor, Brian C. Allen, Matthew Kappus, Lubna Bhatti, Randa A. Dafalla, Laurie D. Snyder, and Mustafa R. Bashir. “Repeatability of Computerized Tomography-Based Anthropomorphic Measurements of Frailty in Patients With Pulmonary Fibrosis Undergoing Lung Transplantation.” Curr Probl Diagn Radiol 46, no. 4 (July 2017): 300–304. https://doi.org/10.1067/j.cpradiol.2016.12.009.
       Full Text  Link to Item
    • Castleberry, Anthony, Michael S. Mulvihill, Babatunde A. Yerokun, Brian C. Gulack, Brian Englum, Laurie Snyder, Mathias Worni, et al. “The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates.” J Heart Lung Transplant 36, no. 7 (July 2017): 780–86. https://doi.org/10.1016/j.healun.2016.12.015.
       Full Text  Link to Item
    • Casciello, Nicole, Amanda Hulbert, Laurie Snyder, and Jennifer Byrns. “Incidence of acute cellular rejection following granulocyte colony-stimulating factor administration in lung transplantation: A retrospective case-cohort analysis.” Clin Transplant 31, no. 5 (May 2017). https://doi.org/10.1111/ctr.12965.
       Full Text  Link to Item
    • Osho, Asishana A., Anthony W. Castleberry, Babatunde A. Yerokun, Michael S. Mulvihill, Justin Rucker, Laurie D. Snyder, Robert D. Davis, and Matthew G. Hartwig. “Clinical predictors and outcome implications of early readmission in lung transplant recipients.” J Heart Lung Transplant 36, no. 5 (May 2017): 546–53. https://doi.org/10.1016/j.healun.2016.11.001.
       Full Text  Link to Item
    • Osho, Asishana A., Sameer A. Hirji, Anthony W. Castleberry, Michael S. Mulvihill, Asvin M. Ganapathi, Paul J. Speicher, Babatunde Yerokun, Laurie D. Snyder, Robert D. Davis, and Mathew G. Hartwig. “Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry.” Clin Transplant 31, no. 5 (May 2017). https://doi.org/10.1111/ctr.12953.
       Full Text  Link to Item
    • Ganapathi, Asvin M., Michael S. Mulvihill, Brian R. Englum, Paul J. Speicher, Brian C. Gulack, Asishana A. Osho, Babatunde A. Yerokun, Laurie R. Snyder, Duane Davis, and Matthew G. Hartwig. “Transplant size mismatch in restrictive lung disease.” Transpl Int 30, no. 4 (April 2017): 378–87. https://doi.org/10.1111/tri.12913.
       Full Text  Link to Item
    • Waldron, Nathan H., Rebecca Y. Klinger, Matthew G. Hartwig, Laurie D. Snyder, James P. Daubert, and Joseph P. Mathew. “Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: A meta-analysis and systematic review of the literature.” Clin Transplant 31, no. 4 (April 2017). https://doi.org/10.1111/ctr.12926.
       Full Text  Link to Item
    • Vacha, Mary, Godefroy Chery, Amanda Hulbert, Jennifer Byrns, Clark Benedetti, Catherine Ashley Finlen Copeland, Alice Gray, Oluwatoyosi Onwuemene, Scott M. Palmer, and Laurie D. Snyder. “Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?” Clin Transplant 31, no. 3 (March 2017). https://doi.org/10.1111/ctr.12886.
       Full Text  Link to Item
    • Smith, Patrick J., James A. Blumenthal, Laurie D. Snyder, Joseph P. Mathew, Michael T. Durheim, Benson M. Hoffman, Sarah K. Rivelli, and Scott M. Palmer. “Depressive symptoms and early mortality following lung transplantation: A pilot study.” Clin Transplant 31, no. 2 (February 2017). https://doi.org/10.1111/ctr.12874.
       Full Text  Link to Item
    • Castleberry, Anthony W., Muath Bishawi, Mathias Worni, Loretta Erhunmwunsee, Paul J. Speicher, Asishana A. Osho, Laurie D. Snyder, and Matthew G. Hartwig. “Medication Nonadherence After Lung Transplantation in Adult Recipients.” Ann Thorac Surg 103, no. 1 (January 2017): 274–80. https://doi.org/10.1016/j.athoracsur.2016.06.067.
       Full Text  Link to Item
    • Snyder, Laurie D. “It Is Not the Flicker but the Fire: Severity Matters in Viral infections After Lung Transplant.” Transplantation 100, no. 11 (November 2016): 2248. https://doi.org/10.1097/TP.0000000000001347.
       Full Text  Link to Item
    • Hartwig, M. G., A. M. Ganapathi, A. A. Osho, S. A. Hirji, B. R. Englum, P. J. Speicher, S. M. Palmer, R. D. Davis, and L. D. Snyder. “Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time.” Am J Transplant 16, no. 11 (November 2016): 3270–77. https://doi.org/10.1111/ajt.13892.
       Full Text  Link to Item
    • DerHovanessian, Ariss, Jamie L. Todd, Alice Zhang, Ning Li, Aradhna Mayalall, C Ashley Finlen Copeland, Michael Shino, et al. “Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.” Ann Am Thorac Soc 13, no. 5 (May 2016): 627–35. https://doi.org/10.1513/AnnalsATS.201510-719OC.
       Full Text  Link to Item
    • Diamond, Joshua M., Mary K. Porteous, L Jackson Roberts, Nancy Wickersham, Melanie Rushefski, Steven M. Kawut, Rupal J. Shah, et al. “The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.” J Heart Lung Transplant 35, no. 4 (April 2016): 500–507. https://doi.org/10.1016/j.healun.2015.12.012.
       Full Text  Link to Item
    • Levine, Deborah J., Allan R. Glanville, Christina Aboyoun, John Belperio, Christian Benden, Gerald J. Berry, Ramsey Hachem, et al. “Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.” J Heart Lung Transplant 35, no. 4 (April 2016): 397–406. https://doi.org/10.1016/j.healun.2016.01.1223.
       Full Text  Link to Item
    • Cantu, E., Y. Suzuki, J. M. Diamond, J. Ellis, J. Tiwari, B. Beduhn, J. R. Nellen, et al. “Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.” Am J Transplant 16, no. 3 (March 2016): 833–40. https://doi.org/10.1111/ajt.13525.
       Full Text  Link to Item
    • Englum, Brian R., Asvin M. Ganapathi, Paul J. Speicher, Brian C. Gulack, Laurie D. Snyder, R Duane Davis, and Matthew G. Hartwig. “Impact of donor and recipient hepatitis C status in lung transplantation.” J Heart Lung Transplant 35, no. 2 (February 2016): 228–35. https://doi.org/10.1016/j.healun.2015.10.012.
       Full Text  Link to Item
    • Snyder, Laurie D., Cliburn Chan, Darongsae Kwon, John S. Yi, Jessica A. Martissa, C Ashley Finlen Copeland, Robyn J. Osborne, Sara D. Sparks, Scott M. Palmer, and Kent J. Weinhold. “Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.” Am J Respir Crit Care Med 193, no. 1 (January 1, 2016): 78–85. https://doi.org/10.1164/rccm.201504-0733OC.
       Full Text  Link to Item
    • Gulack, Brian C., Asvin M. Ganapathi, Paul J. Speicher, James M. Meza, Sameer A. Hirji, Laurie D. Snyder, R Duane Davis, and Matthew G. Hartwig. “What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis?” Ann Thorac Surg 100, no. 5 (November 2015): 1826–33. https://doi.org/10.1016/j.athoracsur.2015.05.008.
       Full Text  Link to Item
    • Castleberry, Anthony W., Brian R. Englum, Laurie D. Snyder, Mathias Worni, Asishana A. Osho, Brian C. Gulack, Scott M. Palmer, R Duane Davis, and Matthew G. Hartwig. “The utility of preoperative six-minute-walk distance in lung transplantation.” Am J Respir Crit Care Med 192, no. 7 (October 1, 2015): 843–52. https://doi.org/10.1164/rccm.201409-1698OC.
       Full Text  Link to Item
    • Durheim, Michael T., Harold R. Collard, Rhonda S. Roberts, Kevin K. Brown, Kevin R. Flaherty, Talmadge E. King, Scott M. Palmer, et al. “Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.” Lancet Respir Med 3, no. 5 (May 2015): 388–96. https://doi.org/10.1016/S2213-2600(15)00093-4.
       Full Text  Link to Item
    • Osho, Asishana A., Anthony W. Castleberry, Laurie D. Snyder, Asvin M. Ganapathi, Paul J. Speicher, Sameer A. Hirji, Mark Stafford-Smith, Mani A. Daneshmand, R. Duane Davis, and Matthew G. Hartwig. “Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate.” J Heart Lung Transplant 34, no. 4 (April 2015): 571–79. https://doi.org/10.1016/j.healun.2014.09.035.
       Full Text  Link to Item
    • Sayah, David M., Beñat Mallavia, Fengchun Liu, Guadalupe Ortiz-Muñoz, Axelle Caudrillier, Ariss DerHovanessian, David J. Ross, et al. “Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.” Am J Respir Crit Care Med 191, no. 4 (February 15, 2015): 455–63. https://doi.org/10.1164/rccm.201406-1086OC.
       Full Text  Link to Item
    • Foster, Matthew W., Lake D. Morrison, Jamie L. Todd, Laurie D. Snyder, J Will Thompson, Erik J. Soderblom, Kelly Plonk, et al. “Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.” J Proteome Res 14, no. 2 (February 6, 2015): 1238–49. https://doi.org/10.1021/pr501149m.
       Full Text  Link to Item
    • Osho, Asishana A., Anthony W. Castleberry, Laurie D. Snyder, Scott M. Palmer, Asvin M. Ganapathi, Sameer A. Hirji, Shu S. Lin, R Duane Davis, and Matthew G. Hartwig. “Differential outcomes with early and late repeat transplantation in the era of the lung allocation score.” Ann Thorac Surg 98, no. 6 (December 2014): 1914–20. https://doi.org/10.1016/j.athoracsur.2014.06.036.
       Full Text  Link to Item
    • Osho, Asishana A., Anthony W. Castleberry, Laurie D. Snyder, Scott M. Palmer, Mark Stafford-Smith, Shu S. Lin, R. Duane Davis, and Matthew G. Hartwig. “The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation.” J Heart Lung Transplant 33, no. 12 (December 2014): 1248–54. https://doi.org/10.1016/j.healun.2014.06.011.
       Full Text  Link to Item
    • Osho, Asishana A., Anthony W. Castleberry, Laurie D. Snyder, Asvin M. Ganapathi, Sameer A. Hirji, Mark Stafford-Smith, Shu S. Lin, R Duane Davis, and Matthew G. Hartwig. “Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation.” Ann Thorac Surg 98, no. 1 (July 2014): 283–89. https://doi.org/10.1016/j.athoracsur.2014.03.010.
       Full Text  Link to Item
    • Silhan, Leann L., Pali D. Shah, Daniel C. Chambers, Laurie D. Snyder, Gerdt C. Riise, Christa L. Wagner, Eva Hellström-Lindberg, et al. “Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.” Eur Respir J 44, no. 1 (July 2014): 178–87. https://doi.org/10.1183/09031936.00060014.
       Full Text  Link to Item
    • Snyder, L. D., A. L. Gray, J. M. Reynolds, G. M. Arepally, A. Bedoya, M. G. Hartwig, R. D. Davis, et al. “Antibody desensitization therapy in highly sensitized lung transplant candidates.” Am J Transplant 14, no. 4 (April 2014): 849–56. https://doi.org/10.1111/ajt.12636.
       Full Text  Link to Item
    • Todd, Jamie L., Rahil Jain, Elizabeth N. Pavlisko, C Ashley Finlen Copeland, John M. Reynolds, Laurie D. Snyder, and Scott M. Palmer. “Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.” Am J Respir Crit Care Med 189, no. 2 (January 15, 2014): 159–66. https://doi.org/10.1164/rccm.201306-1155OC.
       Full Text  Link to Item
    • Shah, P., L. D. Snyder, L. L. Silhan, G. Riise, M. Arcasoy, C. Wagner, J. Mewton, et al. “International Experience Of Lung Transplant In Telomerase Mutation Carriers With Idiopathic Pulmonary Fibrosis.” American Journal of Respiratory and Critical Care Medicine 189 (January 1, 2014).
       Link to Item
    • Castleberry, Anthony W., Mathias Worni, Maragatha Kuchibhatla, Shu S. Lin, Laurie D. Snyder, Scott L. Shofer, Scott M. Palmer, Ricardo Pietrobon, R Duane Davis, and Matthew G. Hartwig. “A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection.” Ann Thorac Surg 96, no. 3 (September 2013): 1008–17. https://doi.org/10.1016/j.athoracsur.2013.01.104.
       Full Text  Link to Item
    • Castleberry, Anthony W., Mathias Worni, Asishana A. Osho, Laurie D. Snyder, Scott M. Palmer, Ricardo Pietrobon, R Duane Davis, and Matthew G. Hartwig. “Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation.” Am J Respir Crit Care Med 188, no. 4 (August 15, 2013): 466–73. https://doi.org/10.1164/rccm.201303-0588OC.
       Full Text  Link to Item
    • Lobo, L. J., J. M. Reynolds, and L. D. Snyder. “Rituximab-associated progressive multifocal leukoencephalopathy after lung transplantation.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 32, no. 7 (July 1, 2013): 752–53.
    • Lobo, Leonard J., John M. Reynolds, and Laurie D. Snyder. “Rituximab-associated progressive multifocal leukoencephalopathy after lung transplantation.” J Heart Lung Transplant 32, no. 7 (July 2013): 752–53. https://doi.org/10.1016/j.healun.2013.04.007.
       Full Text  Link to Item
    • Snyder, Laurie D., Ziwei Wang, Dong-Feng Chen, Nancy L. Reinsmoen, C Ashley Finlen-Copeland, W Austin Davis, David W. Zaas, and Scott M. Palmer. “Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.” Chest 144, no. 1 (July 2013): 226–33. https://doi.org/10.1378/chest.12-0587.
       Full Text  Link to Item
    • Osho, A. A., A. W. Castleberry, L. D. Snyder, S. M. Palmer, S. S. Lin, R. D. Davis, and M. G. Hartwig. “Clinical Predictors and Outcome Implications of 30-Day Hospital Readmission in Lung Transplant Recipients.” The Journal of Heart and Lung Transplantation 32, no. 4 (April 2013): S265–66. https://doi.org/10.1016/j.healun.2013.01.693.
       Full Text
    • Weigt, S. S., CA Finlen Copeland, A. Derhovanessian, M. Y. Shino, W. A. Davis, L. D. Snyder, A. L. Gregson, et al. “Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.” Am J Transplant 13, no. 4 (April 2013): 919–27. https://doi.org/10.1111/ajt.12131.
       Full Text  Link to Item
    • Shofer, S. L., M. M. Wahidi, W. A. Davis, S. M. Palmer, M. G. Hartwig, Y. Lu, and L. D. Snyder. “Significance of and risk factors for the development of central airway stenosis after lung transplantation.” Am J Transplant 13, no. 2 (February 2013): 383–89. https://doi.org/10.1111/ajt.12017.
       Full Text  Link to Item
    • Bedoya, A. D., J. L. Todd, T. Martinu, S. M. Palmer, and L. D. Snyder. “Lung Transplantation For Pulmonary Complications After Bone Marrow Transplantation.” American Journal of Respiratory and Critical Care Medicine 187 (January 1, 2013).
       Link to Item
    • Snyder, L. D., Z. Wang, N. Patel, A. L. Gray, J. Reynolds, R. D. Davis, and S. M. Palmer. “Initial Desensitization Therapy Experience In Lung Transplant Candidates With Elevated Human Leukocyte Antigen Antibodies.” American Journal of Respiratory and Critical Care Medicine 187 (January 1, 2013).
       Link to Item
    • Kelly, F. L., V. E. Kennedy, R. Jain, N. S. Sindhwani, C. A. Finlen Copeland, L. D. Snyder, J. P. Eu, et al. “Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.” Am J Transplant 12, no. 11 (November 2012): 3076–84. https://doi.org/10.1111/j.1600-6143.2012.04201.x.
       Full Text  Link to Item
    • Davis, W. A., C. A. Finlen Copeland, J. L. Todd, L. D. Snyder, J. A. Martissa, and S. M. Palmer. “Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.” Am J Transplant 12, no. 3 (March 2012): 745–52. https://doi.org/10.1111/j.1600-6143.2011.03849.x.
       Full Text  Link to Item
    • Patel, N., L. D. Snyder, A. Finlen-Copeland, and S. M. Palmer. “Is prevention the best treatment? CMV after lung transplantation.” Am J Transplant 12, no. 3 (March 2012): 539–44. https://doi.org/10.1111/j.1600-6143.2011.03837.x.
       Full Text  Link to Item
    • Gowdy, Kymberly M., Julia L. Nugent, Tereza Martinu, Erin Potts, Laurie D. Snyder, W Michael Foster, and Scott M. Palmer. “Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.” Am J Respir Cell Mol Biol 46, no. 2 (February 2012): 249–56. https://doi.org/10.1165/rcmb.2011-0131OC.
       Full Text  Link to Item
    • Finlen Copeland, C Ashley, W Austin Davis, Laurie D. Snyder, Missy Banks, Robin Avery, R Duane Davis, and Scott M. Palmer. “Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.” J Heart Lung Transplant 30, no. 9 (September 2011): 990–96. https://doi.org/10.1016/j.healun.2011.02.017.
       Full Text  Link to Item
    • Hartwig, Matthew G., Deverick J. Anderson, Mark W. Onaitis, Shekur Reddy, Laurie D. Snyder, Shu S. Lin, and R Duane Davis. “Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux.” Ann Thorac Surg 92, no. 2 (August 2011): 462–68. https://doi.org/10.1016/j.athoracsur.2011.04.035.
       Full Text  Link to Item
    • Martinu, Tereza, Christine V. Kinnier, Kymberly M. Gowdy, Francine L. Kelly, Laurie D. Snyder, Dianhua Jiang, W Michael Foster, et al. “Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.” J Heart Lung Transplant 30, no. 6 (June 2011): 717–25. https://doi.org/10.1016/j.healun.2011.01.711.
       Full Text  Link to Item
    • Snyder, L. D., R. Medinas, C. Chan, S. Sparks, W. A. Davis, S. M. Palmer, and K. J. Weinhold. “Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.” Am J Transplant 11, no. 3 (March 2011): 553–60. https://doi.org/10.1111/j.1600-6143.2010.03405.x.
       Full Text  Link to Item
    • Finlen Copeland, C Ashley, Laurie D. Snyder, David W. Zaas, W Jackson Turbyfill, W Austin Davis, and Scott M. Palmer. “Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.” Am J Respir Crit Care Med 182, no. 6 (September 15, 2010): 784–89. https://doi.org/10.1164/rccm.201002-0211OC.
       Full Text  Link to Item
    • Snyder, Laurie D., C Ashley Finlen-Copeland, W Jackson Turbyfill, David Howell, Daniel A. Willner, and Scott M. Palmer. “Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.” Am J Respir Crit Care Med 181, no. 12 (June 15, 2010): 1391–96. https://doi.org/10.1164/rccm.200911-1786OC.
       Full Text  Link to Item
    • Copeland, C Finlen, F. L. Kelly, L. D. Snyder, and S. M. Palmer. “Clinical And Genetic Predictors Of Pulmonary Aspergillus Infection, A Major Risk Factor For Bronchiolitis Obliterans Syndrome After Lung Transplantation.” American Journal of Respiratory and Critical Care Medicine 181 (January 1, 2010).
       Link to Item
    • Gowdy, K., J. L. Nugent, L. D. Snyder, T. Martinu, and S. M. Palmer. “LPS Potentiates Th17 And Th2 Mediated Chronic Pulmonary Graft-Versus-Host Disease (GVHD) After Allogeneic Bone Marrow Transplant (BMT).” American Journal of Respiratory and Critical Care Medicine 181 (January 1, 2010).
       Link to Item
    • Snyder, L. D., T. Dick, W. A. Davis, D. Chen, B. Reams, S. M. Palmer, and D. W. Zaas. “Rituximab For The Treatment Of Humoral Rejection After Human Lung Transplant.” American Journal of Respiratory and Critical Care Medicine 181 (January 1, 2010).
       Link to Item
    • Snyder, Laurie D., and Scott M. Palmer. “Toll-like receptors, innate immunity and lung transplantation.” Front Biosci (Elite Ed) 1, no. 2 (June 1, 2009): 600–604. https://doi.org/10.2741/e58.
       Full Text  Link to Item
    • Wahidi, Momen M., Daniel A. Willner, Laurie D. Snyder, Jeremy L. Hardison, Jessica Y. Chia, and Scott M. Palmer. “Diagnosis and outcome of early pleural space infection following lung transplantation.” Chest 135, no. 2 (February 2009): 484–91. https://doi.org/10.1378/chest.08-1339.
       Full Text  Link to Item
    • Copeland, CA Finlen, W. J. Turbyfill, D. A. Willner, D. W. Zaas, L. D. Snyder, and S. M. Palmer. “Predictors of Survival after Onset of BOS in Lung Transplant Recipients.” American Journal of Respiratory and Critical Care Medicine 179 (January 1, 2009).
       Link to Item
    • Hartwig, Matthew G., Laurie D. Snyder, Ashley Finlen-Copeland, Shu S. Lin, David W. Zaas, R Duane Davis, and Scott M. Palmer. “Lung transplantation at Duke University.” Clin Transpl, 2009, 197–210.
       Link to Item
    • Martinu, T., C. V. Kinnier, K. Gowdy, R. L. Smith, F. L. Kelly, L. D. Snyder, D. Jiang, et al. “CXCR3-Chemokine Pathway in a Model of Murine Alloimmune Lymphocytic Bronchiolitis (AlloLB).” American Journal of Respiratory and Critical Care Medicine 179 (January 1, 2009).
       Link to Item
    • Sindhwani, N Sandhu, A. Finlen-Copeland, F. Kelly, R. Smith, L. D. Snyder, B. R. Stripp, and S. M. Palmer. “Clara Cell Secretory Protein as an Inflammatory Mediator in the Development of BOS.” American Journal of Respiratory and Critical Care Medicine 179 (January 1, 2009).
       Link to Item
    • Turbyfill, W. J., CA Finlen Copeland, D. A. Willner, D. N. Howell, L. D. Snyder, and S. M. Palmer. “Early CMV Pneumonitis Predicts the Development of BOS.” American Journal of Respiratory and Critical Care Medicine 179 (January 1, 2009).
       Link to Item
    • Hartwig, Matthew G., Laurie D. Snyder, James Z. Appel, Ed Cantu, Shu S. Lin, Scott M. Palmer, and R Duane Davis. “Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation.” J Heart Lung Transplant 27, no. 5 (May 2008): 547–53. https://doi.org/10.1016/j.healun.2008.01.022.
       Full Text  Link to Item
    • Reams, B. D., L. W. Musselwhite, D. W. Zaas, M. P. Steele, S. Garantziotis, P. C. Eu, L. D. Snyder, et al. “Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.” Am J Transplant 7, no. 12 (December 2007): 2802–8. https://doi.org/10.1111/j.1600-6143.2007.02000.x.
       Full Text  Link to Item
    • Garantziotis, Stavros, Scott M. Palmer, Laurie D. Snyder, Tonya Ganous, Benny J. Chen, Tie Wang, Donald N. Cook, and David A. Schwartz. “Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.” Transplantation 84, no. 8 (October 27, 2007): 1012–19. https://doi.org/10.1097/01.tp.0000286040.85007.89.
       Full Text  Link to Item
    • Snyder, L. D., L. W. Musselwhite, and S. M. Palmer. “Lung transplantation in the older patient.” Current Opinion in Organ Transplantation 12, no. 5 (October 1, 2007): 485–90. https://doi.org/10.1097/MOT.0b013e32828d8b7c.
       Full Text
    • Palmer, S. M., W. Klimecki, L. Yu, N. L. Reinsmoen, L. D. Snyder, T. M. Ganous, L. Burch, and D. A. Schwartz. “Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14.” Am J Transplant 7, no. 3 (March 2007): 693–99. https://doi.org/10.1111/j.1600-6143.2007.01669.x.
       Full Text  Link to Item
    • Snyder, Laurie D., Ashley Finlen-Copeland, Matthew G. Hartwig, Shu S. Lin, R Duane Davis, and Scott M. Palmer. “Lung transplantation at Duke University Medical Center.” Clin Transpl, 2007, 99–111.
       Link to Item
    • Snyder, Laurie D., Matthew G. Hartwig, Tonya Ganous, R Duane Davis, Walter F. Herczyk, Nancy L. Reinsmoen, David A. Schwartz, and Scott M. Palmer. “Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant.” J Heart Lung Transplant 25, no. 11 (November 2006): 1330–35. https://doi.org/10.1016/j.healun.2006.07.001.
       Full Text  Link to Item
    • Snyder, Laurie D., and Scott M. Palmer. “Immune mechanisms of lung allograft rejection.” Semin Respir Crit Care Med 27, no. 5 (October 2006): 534–43. https://doi.org/10.1055/s-2006-954610.
       Full Text  Link to Item
    • Snyder, Laurie D., and Scott M. Palmer. “Quality, quantity, or both? Life after lung transplantation.” Chest 128, no. 3 (September 2005): 1086–87. https://doi.org/10.1378/chest.128.3.1086.
       Full Text  Link to Item
    • Snyder, Laurie D., and Mark D. Eisner. “Obstructive lung disease among the urban homeless.” Chest 125, no. 5 (May 2004): 1719–25. https://doi.org/10.1378/chest.125.5.1719.
       Full Text  Link to Item
    • Snyder, Laurie, Paul D. Blanc, Patricia P. Katz, Edward H. Yelin, and Mark D. Eisner. “Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma?” Arch Intern Med 164, no. 6 (March 22, 2004): 617–22. https://doi.org/10.1001/archinte.164.6.617.
       Full Text  Link to Item
    • Snyder, L. D., and S. M. Palmer. “Posttransplant lymphoproliferative disorders in lung transplant.” Current Opinion in Organ Transplantation 9, no. 3 (January 1, 2004): 325–31. https://doi.org/10.1097/01.mot.0000135415.90704.92.
       Full Text

  • Conference Papers

    • Clausen, Emily S., Jeremy M. Weber, Kathleen J. Ramos, and Laurie D. Snyder. “Survival difference between high-risk and low-risk CFTR genotypes after lung transplant.” In J Heart Lung Transplant, 2022. https://doi.org/10.1016/j.healun.2022.04.009.
       Full Text  Link to Item
    • De Andrade, J. A., M. L. Neely, A. S. Hellkamp, D. A. Culver, H. J. Kim, T. Liesching, L. J. Lobo, et al. “Effect of Antifibrotic Therapy on Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 205, 2022.
       Link to Item
    • Povysil, G., J. L. Todd, A. S. Allen, D. F. Dilling, H. J. Kim, M. L. Neely, I. Noth, et al. “Gene-Based Collapsing Genetic Analyses to Identify Rare Protein-Coding Variants Associated with Susceptibility to Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 205, 2022.
       Link to Item
    • Todd, J. L., G. Povysil, A. S. Allen, D. F. Dilling, H. J. Kim, M. L. Neely, I. Noth, et al. “Association of Genetic Variants with Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 205, 2022.
       Link to Item
    • Andrade, Joao A. de, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Kalpalatha Guntupalli, Shaun Bender, Craig S. Conoscenti, Laurie D. Snyder, and Laurie D. IPF-PRO Registry investigators. “Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry.” In Respir Med, 189:106637, 2021. https://doi.org/10.1016/j.rmed.2021.106637.
       Full Text  Link to Item
    • De Andrade, J. A., T. Kulkarni, M. L. Neely, A. S. Hellkamp, A Hajari Case, D. A. Culver, K. Guntupalli, S. Bender, C. S. Conoscenti, and L. D. Snyder. “Exploring Relationships Between Resources and Practices of ILD Centers and Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 203, 2021.
       Link to Item
    • Kim, H., L. D. Snyder, A. Adegunsoye, M. L. Neely, S. Bender, E. S. White, C. S. Conoscenti, and M. E. Strek. “Post-Hospitalization Mortality in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 203, 2021.
       Link to Item
    • Levy, L., M. Ahmed, E. Huszti, C. K. Zhang, S. E. Hunter, K. M. Boonstra, A. T. Sage, et al. “Bronchoalveolar Bile Acids are Associated with Acute Rejection, Inflammation, and Allograft Survival: A Multi-Center Study.” In Journal of Heart and Lung Transplantation, 40:S62–63, 2021.
       Link to Item
    • Magin, J., L. D. Snyder, C. Wolfe, and H. A. Ali. “A Rare Case of Symmetrical Cutaneous Alternaria Infections after Bilateral Lung Transplant.” In Journal of Heart and Lung Transplantation, 40:S513–14, 2021.
       Link to Item
    • Magin, J., L. D. Snyder, and H. A. Ali. “Transbronchial Biopsy Yields After the First Year Post-Lung Transplantation.” In American Journal of Respiratory and Critical Care Medicine, Vol. 203, 2021.
       Link to Item
    • Schneeberger, P. H., C. Zhang, J. Santilli, Z. Wijesinha, L. Levy, B. Chen, W. Xu, et al. “The Pulmonary Microbiome after Lung Transplantation is Associated with Gastroesophageal Reflux Disease, Inflammation, and Allograft Dysfunction.” In Journal of Heart and Lung Transplantation, 40:S59–60, 2021.
       Link to Item
    • Strek, M. E., L. D. Snyder, A. Adegunsoye, M. L. Neely, S. Bender, E. S. White, C. S. Conoscenti, and H. J. Kim. “Characteristics of Patients with Idiopathic Pulmonary Fibrosis Admitted to Hospital: Data from the IPF-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 203, 2021.
       Link to Item
    • Zaffiri, Lorenzo, Alex Long, Megan L. Neely, Wida S. Cherikh, Daniel C. Chambers, and Laurie D. Snyder. “Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry.” In J Heart Lung Transplant, 39:1089–99, 2020. https://doi.org/10.1016/j.healun.2020.06.010.
       Full Text  Link to Item
    • Aversa, M., D. R. Darley, A. Hirji, L. Snyder, D. Lyu, F. Parquin, M. Perch, et al. “Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S315, 2020. https://doi.org/10.1016/j.healun.2020.01.709.
       Full Text
    • Cantu, E., C. Bermudez, M. Cevasco, Y. Suzuki, T. Buckley, V. Galati, N. Majeti, et al. “Implications of ECMO Bridging and Salvage Strategies on Mortality and PGD.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S103–4, 2020. https://doi.org/10.1016/j.healun.2020.01.960.
       Full Text
    • Choi, A. Y., V. Raman, O. K. Jawitz, S. E. Halpern, B. S. Bryner, L. D. Snyder, and M. G. Hartwig. “Five Year Follow-Up of Staged Bilateral Lung Transplantation for High-Risk Patients with Interstitial Lung Disease: A Matched Case-Control Study.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S380–81, 2020. https://doi.org/10.1016/j.healun.2020.01.486.
       Full Text
    • Frankel, C. W., H. Kopetskie, M. Sever, M. Cosgrove, J. Kirchner, M. Robien, N. Williams, et al. “Prospective Assessment of Chronic Lung Allograft Dysfunction (CLAD); the Clinical Trials in Organ Transplantation (CTOT) Study Experience.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S303, 2020. https://doi.org/10.1016/j.healun.2020.01.677.
       Full Text
    • Rozenberg, D., L. G. Singer, M. L. Neely, J. M. Weber, H. A. Kopetskie, M. L. Sever, J. Kirchner, et al. “Agreement between Fried Frailty Phenotype and Cumulative Deficits Frailty Indices: A Prospective Multi-Center Study.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S314, 2020. https://doi.org/10.1016/j.healun.2020.01.707.
       Full Text
    • Shino, M. Y., R. M. Elashoff, N. Li, J. L. Todd, M. L. Neely, H. Kopetskie, M. Sever, et al. “A Multi-Center Study of BAL CXCR3 Chemokines during Allograft Injury after Lung Transplantation.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S115, 2020. https://doi.org/10.1016/j.healun.2020.01.990.
       Full Text
    • Todd, J. L., F. L. Kelly, M. L. Neely, K. Keslar, E. N. Pavlisko, S. J. McCall, A. Fletcher, et al. “NanoString Gene Expression Profiling in Chronic Lung Allograft Dysfunction (CLAD).” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S113, 2020. https://doi.org/10.1016/j.healun.2020.01.985.
       Full Text
    • Zhang, C., P. H. Schneeberger, L. Levy, Y. Lee, E. Huszti, S. E. Hunter, M. Ahmed, et al. “Pulmonary Microbiome Changes in Lung Transplant Recipients with Gastroesophageal Reflux.” In The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39:S105, 2020. https://doi.org/10.1016/j.healun.2020.01.963.
       Full Text
    • Magin, J., M. Dorry, C. Frankel, L. D. Snyder, and T. Dahhan. “The Association of Post-Transplant Pulmonary Embolism with the Development of Chronic Lung Allograft Dysfunction.” In American Journal of Respiratory and Critical Care Medicine, Vol. 201, 2020.
       Link to Item
    • Palmer, S. M., M. L. Neely, J. A. Belperio, S. Bender, D. A. Culver, J. De Andrade, E. C. O’Brien, et al. “Improving Our Understanding of Progressive Fibrosing Interstitial Lung Diseases (ILDs): Design of the ILD-PRO Registry.” In American Journal of Respiratory and Critical Care Medicine, Vol. 201, 2020.
       Link to Item
    • Snyder, L. D., G. Safioti, M. Reich, M. Neely, N. Lugogo, R. A. Pleasants, T. Li, L. Granovsky, and M. DePietro. “A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open-Label Study.” In American Journal of Respiratory and Critical Care Medicine, Vol. 201, 2020.
       Link to Item
    • Snyder, L. D., G. Safioti, M. Reich, M. Neely, N. Lugogo, R. A. Pleasants, T. Liz, L. Granovsky, and M. DePietro. “Objective Assessment of Rescue Medication Use and Inhalation Characteristics of COPD Patients Recorded by the Electronic ProAir Digihaler.” In American Journal of Respiratory and Critical Care Medicine, Vol. 201, 2020.
       Link to Item
    • Turner, D., P. J. Smith, L. G. Singer, and L. D. Snyder. “Novel Cumulative Deficits Frailty Index Associated with Early Outcomes in Lung Transplant Recipients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 201, 2020.
       Link to Item
    • Ahmed, M., L. Levy, S. E. Hunter, K. C. Zhang, E. Huszti, K. M. Boonstra, A. T. Sage, et al. “Lung Bile Acid as Biomarker of Microaspiration and Its Relationship to Lung Inflammation.” In The Journal of Heart and Lung Transplantation, 38:S255–56. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.635.
       Full Text
    • Pavlisko, E. N., M. L. Neely, H. Kopetskie, D. Hwang, C. F. Farver, A. V. Arrossi, W. D. Wallace, et al. “Occurrence and Risk Factors for Acute Lung Injury (ALI) and Organizing Pneumonia (OP) after Lung Transplant.” In The Journal of Heart and Lung Transplantation, 38:S56–57. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.124.
       Full Text
    • Snyder, L. D., M. Neely, H. Kopetskie, M. Sever, J. Kirchner, C. Frankel, J. Todd, et al. “Improvements in Health-Related Quality of Life with Lung Transplantation: A Prospective Multicenter Cohort Study.” In The Journal of Heart and Lung Transplantation, 38:S328–S328. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.828.
       Full Text
    • Todd, J. L., M. L. Neely, H. Kopetskie, M. Sever, J. Kirchner, C. W. Frankel, L. D. Snyder, et al. “Acute Rejection (AR) and Lymphocytic Bronchiolitis (LB) in a Multicenter Lung Transplant Cohort.” In The Journal of Heart and Lung Transplantation, 38:S402–3. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.1025.
       Full Text
    • Zhang, K. C., S. E. Hunter, E. Huszti, M. Ahmed, L. Levy, K. M. Boonstra, A. T. Sage, et al. “Effects of Nissen Fundoplication on Markers of Microaspiration and Inflammation after Lung Transplantation.” In The Journal of Heart and Lung Transplantation, 38:S73–74. Elsevier BV, 2019. https://doi.org/10.1016/j.healun.2019.01.166.
       Full Text
    • Natalini, J. G., M. Porteous, D. J. Lederer, K. M. Wille, A. B. Weinacker, J. B. Orens, P. M. Shah, et al. “Hospital Length of Stay Following Lung Transplantation for Connective Tissue Disease-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 199. AMER THORACIC SOC, 2019.
       Link to Item
    • Clausen, E. S., L. D. Snyder, S. M. Palmer, A. Gray, and P. J. Smith. “EFFECT OF WEIGHT GAIN PRE-LUNG TRANSPLANT IN RECIPIENTS WITH CYSTIC FIBROSIS.” In Pediatric Pulmonology, 53:352–53. WILEY, 2018.
       Link to Item
    • Thaniyavarn, T., L. D. Snyder, and H. A. Ali. “Influenza Vaccination and de novo Donor Specific Antibody (DSA) in Lung Transplant Recipient: Is There a Causal Relationship?” In American Journal of Respiratory and Critical Care Medicine, Vol. 197. AMER THORACIC SOC, 2018.
       Link to Item
    • Whitson, J. W., L. D. Snyder, and L. Zaffiri. “Post-Transplant Lymphoproliferative Disorder: A Retrospective 17-Year Analysis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 197. AMER THORACIC SOC, 2018.
       Link to Item
    • Mulvihill, Michael S., Brian C. Gulack, Asvin M. Ganapathi, Paul J. Speicher, Brian R. Englum, Sameer A. Hirji, Laurie D. Snyder, R Duane Davis, and Matthew G. Hartwig. “The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation.” In Clin Transplant, Vol. 31, 2017. https://doi.org/10.1111/ctr.12993.
       Full Text  Link to Item
    • Klement, W., J. Tikkanen, S. Juvet, J. L. Todd, S. S. Weigt, L. D. Snyder, S. Azad, et al. “Automating the Diagnosis of Potential CLAD and Its Subtypes in Lung Transplant Recipients.” In Journal of Heart and Lung Transplantation, 36:S309–S309. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Smith, P. J., J. A. Blumenthal, L. D. Snyder, S. Rivelli, and S. M. Palmer. “Perceived Cognitive Difficulties and Quality of Life following Lung Transplantation.” In Journal of Heart and Lung Transplantation, 36:S96–S96. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Smith, P. J., S. M. Palmer, L. D. Snyder, B. M. Hoffman, K. K. Ingle, G. L. Stonerock, C. Saulino, and J. A. Blumenthal. “Depressive Symptoms and Post-Transplant Mortality: Examining the Influence of Perioperative Outcomes.” In Journal of Heart and Lung Transplantation, 36:S208–S208. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Zaffiri, L., C. Frankel, E. N. Pavlisko, S. M. Palmer, and L. D. Snyder. “Post-Transplant Lymphoproliferative Disorder After Lung Transplantation: 10-Year Experience at Duke University.” In Journal of Heart and Lung Transplantation, 36:S95–S95. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Byrd, R., P. Smith, O. Mohamedaly, L. D. Snyder, and Amy Pastva. “Rehabilitation of candidates for lung transplantation: exercise capacity, symptomotology, and quality of life outcomes.” In American Journal of Respiratory and Critical Care Medicine, A2334–A2334. American Thoracic Society, 2017.
    • Dorry, M., L. D. Snyder, and T. Dahhan. “Risk Stratification Of Pulmonary Embolism May Affect Lung Transplant Outcomes.” In American Journal of Respiratory and Critical Care Medicine, Vol. 195. AMER THORACIC SOC, 2017.
       Link to Item
    • Durheim, M. T., P. J. Smith, J. A. Blumenthal, S. M. Palmer, and L. D. Snyder. “Changes In Dyspnea Following Lung Transplantation: A Pooled Cohort Study.” In American Journal of Respiratory and Critical Care Medicine, Vol. 195. AMER THORACIC SOC, 2017.
       Link to Item
    • Frankel, C. W., S. M. Palmer, L. D. Snyder, and P. J. Smith. “Assessment Of Daily Physical Activity In Lung And Heart Transplant Recipients In The First Year Post-Transplant.” In American Journal of Respiratory and Critical Care Medicine, Vol. 195. AMER THORACIC SOC, 2017.
       Link to Item
    • Hoffman, B. M., P. J. Smith, K. K. Ingle, G. L. Stonerock, C. Saulino, S. M. Palmer, L. D. Snyder, J. M. Reynolds, and J. A. Blumenthal. “Coping And Clinical Outcomes Among Lung Transplant Patients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 195. AMER THORACIC SOC, 2017.
       Link to Item
    • Smith, P. J., C. Franckel, R. Byrd, Amy Pastva, S. M. Palmer, and L. D. Snyder. “Depression and functional capacity independently predict mortality following lung transplantation.” In American Journal of Respiratory and Critical Care Medicine, A6734–A6734. American Thoracic Society, 2017.
    • Holland, T., R. Byrd, R. Crouch, M. G. Hartwig, K. Holleman, A. Pastva, J. Reynolds, P. Smith, and L. D. Snyder. “High Rates of Post-Transplant Depressive Symptoms Identified Using the CES-D.” In The Journal of Heart and Lung Transplantation, 35:S342–S342. Elsevier BV, 2016. https://doi.org/10.1016/j.healun.2016.01.979.
       Full Text
    • Holleman, K., T. Holland, L. West, and L. D. Snyder. “The Positive Outcomes for Patients Receiving Animal Assisted Therapy after Lung Transplantation.” In The Journal of Heart and Lung Transplantation, 35:S342–S342. Elsevier BV, 2016. https://doi.org/10.1016/j.healun.2016.01.980.
       Full Text
    • O’Brien, E. C., P. Shrader, M. T. Durheim, L. D. Snyder, J. L. Todd, V. Gamerman, K. J. Anstrom, et al. “Disease Severity And Quality Of Life In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 193. AMER THORACIC SOC, 2016.
       Link to Item
    • Gulack, B. C., A. M. Ganapathi, P. J. Speicher, G. Chery, L. D. Snyder, R. D. Davis, and M. G. Hartwig. “Survival After Lung Transplant in Alpha-1-Antitrypsin Deficiency Recipients Compared to Other Forms of Chronic Obstructive Pulmonary Disease.” In The Journal of Heart and Lung Transplantation, 34:S243–44. Elsevier BV, 2015. https://doi.org/10.1016/j.healun.2015.01.676.
       Full Text
    • Ali, H. A., A. L. Gray, S. Aryal, J. Reynolds, and L. D. Snyder. “Polymicrobial Sepsis Related To Strongyloides Infection In A Lung Transplant Recipient.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Ali, H. A., L. D. Snyder, K. Mahmood, M. M. Wahidi, A. C. Argento, N. A. Larrier, and S. L. Shofer. “High Dose Brachytherapy For Bronchial Stenosis In Lung Transplant Recipients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Ali, H. A., L. D. Snyder, L. F. Diehl, J. L. Todd, and S. Aryal. “Atypical Primary Effusion Lymphoma In A Lung Transplant Recipient.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Chery, G. S., S. M. Palmer, L. D. Snyder, A. L. Gray, J. L. Todd, G. Harrison, and E. N. Pavlisko. “Post-Transplant Lymphoproliferative Disorder Erosion Into A Large Pulmonary Artery With Death Secondary To Hemorrhagic Shock.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Chery, G. S., S. M. Palmer, L. D. Snyder, J. L. Todd, and C. Wolfe. “Brincidofovir In Progressive Multifocal Leukoencephalopathy After Lung Transplant.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Copeland, CA Finlen, J. A. Martissa, C. W. Frankel, E. C. Benedetti, E. Callahan, D. Ross, S. M. Palmer, et al. “A Prospective Multicenter Assessment Of Aztreonam Lysine For Inhalation In The Treatment Of Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Durheim, M. T., H. R. Collard, R. S. Roberts, K. K. Brown, K. R. Flaherty, T. E. King, S. M. Palmer, et al. “Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Frankel, C. W., L. D. Snyder, C Finlen Copeland, E. Benedetti, E. Serrano, J. A. Martissa, and S. M. Palmer. “Inhaled Aztreonam In Lung Transplant Recipients: A Single Center Retrospective Cohort Study.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Lehr, C. J., L. D. Snyder, and S. L. Shofer. “Pleural Effusions Underlying Rejection After Lung Transplantation.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Snyder, L. D., C. Chan, D. Kwon, J. Yi, J. A. Martissa, CA Finlen Copeland, R. Osborne, S. D. Sparks, S. M. Palmer, and K. J. Weinhold. “Polyfunctional T Cell Immunity Predicts Cytomegalovirus Infection After Lung Transplant.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Speicher, Paul J., Asvin M. Ganapathi, Brian R. Englum, Brian C. Gulack, Asishana A. Osho, Sameer A. Hirji, Anthony W. Castleberry, Laurie D. Snyder, R. Duane Davis, and Matthew G. Hartwig. “Single-lung transplantation in the United States: what happens to the other lung?” In J Heart Lung Transplant, 34:36–42, 2015. https://doi.org/10.1016/j.healun.2014.08.018.
       Full Text  Link to Item
    • Englum, B. R., A. M. Ganapathi, P. J. Speicher, B. C. Gulack, S. S. Lin, S. M. Palmer, L. D. Snyder, M. Daneshmand, R. D. Davis, and M. G. Hartwig. “Donor and Recipient Hepatitis C Status in Lung Transplant.” In The Journal of Heart and Lung Transplantation, 33:S182–83. Elsevier BV, 2014. https://doi.org/10.1016/j.healun.2014.01.495.
       Full Text
    • Gries, C. J., M. Budev, L. D. Snyder, J. M. Pilewski, M. Dew, A. DeVito-Dabbs, C. Bermudez, S. J. Patterson, and D. B. White. “What Your Lung Transplant Candidates with Chronic Obstructive Pulmonary Disease (COPD) Want and Expect from Transplant.” In The Journal of Heart and Lung Transplantation, 33:S140–S140. Elsevier BV, 2014. https://doi.org/10.1016/j.healun.2014.01.378.
       Full Text
    • Castleberry, A. W., B. R. Englum, L. D. Snyder, M. Worni, A. A. Osho, R. S. Pietrobon, S. M. Palmer, R. D. Davis, and M. G. Hartwig. “Utility of Six-Minute Walk Distance in Predicting Outcomes after Lung Transplant: A Nationwide Survival Analysis.” In The Journal of Heart and Lung Transplantation, 32:S147–S147. Elsevier BV, 2013. https://doi.org/10.1016/j.healun.2013.01.332.
       Full Text
    • Castleberry, A. W., P. J. Speicher, M. Worni, A. A. Osho, L. D. Snyder, K. L. Gandy, R. S. Pietrobon, R. D. Davis, and M. G. Hartwig. “Socioeconomic Disparities Associated with Medication Non-Adherence Following Lung Transplantation in Adult Recipients.” In The Journal of Heart and Lung Transplantation, 32:S44–45. Elsevier BV, 2013. https://doi.org/10.1016/j.healun.2013.01.916.
       Full Text
    • Gray, A. L., Z. Wang, N. Patel, J. M. Reynolds, R. D. Davis, S. M. Palmer, and L. D. Snyder. “Antibody Directed Therapy after Lung Transplant.” In The Journal of Heart and Lung Transplantation, 32:S170–71. Elsevier BV, 2013. https://doi.org/10.1016/j.healun.2013.01.406.
       Full Text
    • Osho, A. A., A. W. Castleberry, L. D. Snyder, S. M. Palmer, S. S. Lin, R. D. Davis, and M. G. Hartwig. “Optimizing the Estimation of Renal Function in Lung Transplant Candidates.” In The Journal of Heart and Lung Transplantation, 32:S217–S217. Elsevier BV, 2013. https://doi.org/10.1016/j.healun.2013.01.545.
       Full Text
    • Todd, J. L., R. Jain, E. N. Pavlisko, C Finlen Copeland, L. D. Snyder, and S. M. Palmer. “Restrictive Spirometry At Bronchiolitis Obliterans Syndrome Onset Predicts Worse Survival.” In American Journal of Respiratory and Critical Care Medicine, Vol. 187. AMER THORACIC SOC, 2013.
       Link to Item
    • Hartwig, M. G., Z. A. Hashmi, D. Albon, J. T. Martin, A. W. Castleberry, L. D. Snyder, S. M. Palmer, S. S. Lin, and R. D. Davis. “85 Lung Transplantation Is an Effective Treatment Option for Patients over the Age of 70.” In The Journal of Heart and Lung Transplantation, 31:S37–38. Elsevier BV, 2012. https://doi.org/10.1016/j.healun.2012.01.089.
       Full Text
    • Copeland, CA Finlen, W. A. Davis, L. D. Snyder, M. Banks, R. Avery, and S. M. Palmer. “Reduced Lifetime Incidence of Cytomegalovirus with Extended Prophylaxis: Long-Term Follow Up from a Randomized Controlled Trial.” In Journal of Heart and Lung Transplantation, 30:S42–S42. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Snyder, L. D., S. D. Sparks, W. A. Davis, R. Medinas, K. J. Weinhold, and S. M. Palmer. “Polychromatic Flow Cytometry Identifies T Cell Subsets In Human Lung Transplant Recipients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 181. AMER THORACIC SOC, 2010.
       Link to Item
    • Hartwig, M. G., L. D. Snyder, J. Z. Appel, S. Simsir, S. S. Lin, S. M. Palmer, and R. D. Davis. “Rabbit antithymocyte globulin induction therapy for lung transplantation does not affect long-term allograft function or survival.” In The Journal of Heart and Lung Transplantation, 24:S81–82. Elsevier BV, 2005. https://doi.org/10.1016/j.healun.2004.11.143.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.